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Abstract
Introduction:  Shivering,  a  common  intraoperative  problem  under  spinal  anesthesia  increases
the oxygen  consumption  considerably  and  is  uncomfortable  and  distressing  to  the  patient,  anes-
thesiologist  as  well  as  surgeon.  The  present  study  was  designed  to  explore  the  effectiveness  of
tramadol, clonidine  and  dexmedetomidine  in  the  treatment  of  post  spinal  anesthesia  shivering
and to  look  for  their  adverse  effects.
Methods:  This  prospective,  randomized,  double  blinded  control  study  was  done  on  90  patients
who developed  shivering  under  spinal  anesthesia.  They  were  randomly  divided  into  three  groups
with Group  T  receiving  tramadol  1  mg/kg,  Group  C  getting  clonidine  1  mcg/kg  and  Group  D
patients receiving  dexmedetomidine  0.5  mcg/kg.  The  time  taken  to  control  shivering,  recur-
rence rate,  hemodynamic  variables,  sedation  score  and  adverse  effects  were  observed.
Results: Dexmedetomidine  was  faster  in  the  control  of  shivering  in  5.7  ±  0.79  min  whereas  tra-
madol took  6.76  ±  0.93  min  and  clonidine  was  slower  with  9.43  ±  0.93  min.  The  recurrence  rate
was much  lower  in  the  dexmedetomidine  group  with  3.3%  than  for  clonidine  (10%)  and  tra-
madol (23.3%)  group.  The  sedation  achieved  with  dexmedetomidine  was  better  than  clonidine
and tramadol.  The  tramadol  group  had  more  cases  of  vomiting  (four)  and  dexmedetomidine
group had  six  cases  of  hypotension  and  two  cases  of  bradycardia.  Two  of  the  clonidine  patients
encountered  bradycardia  and  hypotension.
Conclusion:  Dexmedetomidine  is  better  than  tramadol  and  clonidine  in  the  control  of  shivering
because of  its  faster  onset  and  less  recurrence  rate.  Though  complications  are  encountered  inp,  they  are  treatable.
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Estudo  prospectivo  randômico,  duplo-cego  e  controlado  comparando  tramadol,
clonidina  e  dexmedetomidina  para  tremores  pós-raquianestesia
Resumo
Introduc¸ão:  Os  tremores  ----  um  problema  comum  no  período  intraoperatório  sob  raquianestesia
---- aumentam  consideravelmente  o  consumo  de  oxigênio  e  são  desconfortáveis  e  angus-
tiantes para  o  paciente,  anestesiologista  e  cirurgião.  O  presente  estudo  foi  concebido  para
explorar a  eﬁcácia  de  tramadol,  clonidina  e  dexmedetomidina  no  tratamento  de  tremores
pós-raquianestesia  e  observar  seus  efeitos  adversos.
Métodos:  Este  estudo  prospectivo,  randômico,  controlado  e  duplo-cego  foi  realizado  com  90
pacientes que  desenvolveram  tremores  sob  raquianestesia.  Os  pacientes  foram  randomicamente
divididos  em  três  grupos  para  receber  1  mg/kg  de  tramadol  (Grupo  T),  1  mcg/kg  de  clonidina
(Grupo C)  e  0,5  mcg/kg  de  dexmedetomidina  (Grupo  D).  O  tempo  necessário  para  controlar  os
tremores,  a  taxa  de  recorrência,  as  variáveis  hemodinâmicas,  os  níveis  de  sedac¸ão  e  os  efeitos
adversos foram  registrados.
Resultados:  Dexmedetomidina  foi  mais  rápida  para  controlar  os  tremores,  com  tempo  de
5,7 ±  0,79  min;  o  tempo  de  tramadol  foi  de  6,76  ±  0,93  min;  clonidina  foi  mais  lenta,  com  tempo
de 9,43  ±  0,93  min.  A  taxa  de  recorrência  foi  muito  menor  no  grupo  dexmedetomidina  (3,3%)
que nos  grupos  clonidina  (10%)  e  tramadol  (23,3%).  A  sedac¸ão  obtida  com  dexmedetomidina  foi
melhor que  a  obtida  com  clonidina  e  tramadol.  O  grupo  tramadol  teve  mais  casos  de  vômito
(quatro); o  grupo  dexmedetomidina  teve  seis  casos  de  hipotensão  e  dois  casos  de  bradicardia.
Dois pacientes  do  grupo  clonidina  apresentaram  bradicardia  e  hipotensão.
Conclusão:  Dexmedetomidina  foi  melhor  que  tramadol  e  clonidina  para  o  controlo  de  tremores
devido ao  seu  início  de  ac¸ão  mais  rápido  e  taxa  de  recorrência  mais  baixa.  Embora  complicac¸ões
tenham sido  observadas  no  grupo  dexmedetomidina,  elas  foram  tratáveis.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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patients  were  excluded  from  the  study.  The  patients  whontroduction
hivering  is  an  oscillatory,  involuntary  mechanical  muscu-
ar  activity  and  a  natural  protective  mechanism  to  the
eduction  of  body  temperature.  The  body  tries  to  raise
he  metabolic  heat  generation  to  restore  homeostasis  by
hivering.1 The  core  temperature  in  humans  is  normally
aintained  within  a  tight  range  of  36.5--37.5 ◦C  which  is
nown  as  the  interthreshold  range  or  thermo  neutral  zone.
hermoregulatory  responses  like  vasoconstriction  and  shiv-
ring  are  activated  when  core  temperature  falls  below  the
ormal  range.2 The  spinal  -motor  neurons  and  their  axons
ediate  the  neurological  mechanism  of  shivering  with  cen-
er  at  the  preoptic  nucleus  of  the  anterior  hypothalamus.3
The  incidence  of  shivering  following  spinal  anesthesia  is
ot  exactly  known  for  references  quoting  as  high  as  30--60%.4
he  shivering  increases  heat  production  up  to  600%  and
xygen  consumption  is  tripled.  This  can  lead  to  several
etabolic  abnormalities  like  hypoxemia,  hypercarbia,  lactic
cidosis,  increased  intraocular  and  intracranial  pressure.5,6
n  patients  with  coronary  artery  disease,  shivering  can  fur-
her  compromise  myocardial  function.7
Several  pharmacologic  and  nonpharmacologic  strategies
re  available  for  the  treatment  of  shivering  with  no  consen-
us  on  the  gold  standard  therapy.8 The  nonpharmacologic
trategies  include  blankets,  warming  intravenous  ﬂuids  andPlease  cite  this  article  in  press  as:  Venkatraman  R,  et  al.  A  p
comparison  of  tramadol,  clonidine  and  dexmedetomidine  for  p
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se  of  external  warmer.  Several  drugs  have  been  stud-
ed  for  the  prophylaxis  as  well  as  treatment  of  shivering.
his  includes  pethidine,  tramadol,  nefopam,  ketamine,
d
d
Gexmedetomidine,  granisetron,  physostigmine,  clonidine,
agnesium  sulphate,  dexamethasone,  and  urapidil.9 But
nfortunately,  no  single  drug  has  been  found  to  be  effec-
ive  and  without  any  adverse  effects.  Pethidine  was  long
onsidered  as  the  agent  of  choice  to  control  shivering  but
any  institutions  are  nowadays  avoiding  pethidine  because
f  its  adverse  effects.8
The  objective  of  this  prospective,  randomized,  double-
linded  control  study  is  to  compare  the  efﬁcacy,  recurrence
ate,  hemodynamics  and  complications  of  tramadol,  cloni-
ine  and  dexmedetomidine  in  the  treatment  of  shivering
ollowing  spinal  anesthesia.
aterials and methods
he  study  was  performed  after  obtaining  institutional  ethi-
al  committee  approval  and  written,  informed  consent  from
atients  in  a  tertiary  medical  college  hospital.  Patients
n  the  age  group  of  18--70,  American  Society  of  Anes-
hesiologists  (ASA)  1  and  2  and  scheduled  to  undergo
lective  surgeries  under  spinal  anesthesia  and  developing
hivering  were  included  in  the  study.  Patients  with  ASA  3
nd  above,  cardiac,  liver  and  renal  diseases,  allergic  to
ny  of  the  study  drugs  or  patient  refusal  and  pregnantrospective,  randomized,  double-blinded  control  study  on
ost  spinal  anesthesia  shivering.  Rev  Bras  Anestesiol.  2016.
eveloped  shivering  under  spinal  anesthesia  were  randomly
ivided  into  three  groups  with  30  patients  in  each  group.
roup  T  patients  received  tramadol  1  mg/kg,  Group  C  had
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clonidine  1 mcg/kg  and  Group  D  received  dexmedetomi-
dine  0.5  mcg/kg.  The  group  allotment  was  decided  by  the
computer  generated  random  envelope  method.  The  ﬁrst
anesthesiologist  opens  the  envelope  and  adds  the  study  drug
in  a  100  mL  normal  saline  and  hands  it  to  the  second  anes-
thesiologist  who  is  blinded  to  the  study  drug.  He  administers
the  drug  over  10  min  and  monitors  the  patient.
Standard  monitoring  of  Electrocardiogram,  noninvasive
blood  pressure,  oxygen  saturation  and  axillary  temperature
were  done  on  all  patients.  The  operating  room  temperature
was  maintained  at  22 ◦C  for  all  the  surgeries.  No  external
warming  devices  were  used  and  ﬂuids  were  administered
at  room  temperature  to  all  patients.  The  patients  received
spinal  anesthesia  with  25  gauge  Quincke  spinal  needle  to
achieve  a  level  of  at  least  T10  depending  on  the  type  of
surgery.  Patients  who  developed  shivering  were  included  in
the  study.  The  shivering  intensity  was  graded  on  a  scale
of  1--4  as  per  Wrench.  Grade  1  was  patients  having  one
or  more  of  the  following:  piloerection,  peripheral  vasocon-
striction,  peripheral  cyanosis,  but  without  visible  muscle
activity.  Grade  2  includes  visible  muscle  activity  conﬁned
to  one  muscle  group.  Grade  3  was  visible  muscle  activity  in
more  than  one  muscle  group.  Grade  4  was  taken  as  gross
muscle  activity  involving  the  whole  body.  The  patients  were
included  in  the  study  when  they  develop  shivering  with  at
least  a  Grade  of  2.
The  hemodynamic  monitoring  was  continued  after  the
administration  of  study  drugs.  The  time  taken  to  control
shivering,  recurrence  and  adverse  effects  like  nausea,  vomi-
ting,  dry  mouth  and  sedation  score  were  observed.  The
sedation  score  proposed  by  Filos  et  al.  was  followed.  Grade  1Please  cite  this  article  in  press  as:  Venkatraman  R,  et  al.  A  p
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was  taken  as  awake  and  alert  patient.  Grade  2  being  drowsy
patient  responding  to  verbal  stimuli.  Grade  3 was  taken  as
drowsy  but  arousable  to  physical  stimuli  and  Grade  4  was
(
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Figure  1  CONSORT  ﬂow  chart  (CONSORT,  Co PRESS
st  spinal  shivering  3
narousable  patient.  The  monitoring  was  continued  for  two
ours  after  the  administration  of  spinal  anesthesia.
Statistical  analysis  was  performed  using  a  standard  sta-
istical  program,  The  Statistical  Package  for  Social  Sciences
ersion  17.0  software  (IBM  Corporation,  Armonk,  NY,  USA).
emographic  data  were  analyzed  using  One-way  Analysis
f  Variance  (ANOVA)  test.  The  time  taken  to  control  shiv-
ring,  heart  rate  and  blood  pressure  were  expressed  as
ean  ±  standard  deviation  and  statistical  analysis  was  done
y  One-way  ANOVA  with  posttest.  The  level  for  all  analyses
as  set  at  p  =  0.05  with  a  p-value  less  than  0.05  were  con-
idered  statistically  signiﬁcant  and  p-value  less  than  0.01
ere  considered  extremely  signiﬁcant.  If  p-value  was  sig-
iﬁcant  then  Students’  t-test  was  done  between  two  groups
o  determine  the  statistical  signiﬁcance.  The  sedation  score,
ecurrence  rate  and  adverse  effects  were  analyzed  using  two
ay  ANOVA  test  for  block  design.
esults
hree  hundred  and  twelve  patients  were  recruited  into  the
tudy  and  a  Consolidated  Standards  of  Reporting  Trials  ﬂow
iagram  depicting  the  passage  of  participants  through  the
rial  has  been  provided  in  Fig.  1.10
The  two  groups  were  comparable  with  respect  to  the
emographic  proﬁle  and  there  was  no  statistically  signiﬁ-
ant  difference  as  shown  in  Table  1.  There  were  also  no
igniﬁcant  baseline  variations  in  hemodynamic  parameters
nd  mean  axillary  temperature.  The  time  taken  to  con-rospective,  randomized,  double-blinded  control  study  on
ost  spinal  anesthesia  shivering.  Rev  Bras  Anestesiol.  2016.
5.76  ±  1.14  min)  group  than  tramadol  (6.72  ±  1.27  min)  and
lonidine  (9.48  ±  0.95  min)  group.  The  p-value  was  <0.0001
hich  was  highly  signiﬁcant  by  One  way  Analysis  of  variance
=312 Excluded (n=222)
Did not develop shivering 
(n=205)
)
s (n=0)
Analysed (n=30)
Excluded from analysis (n=0)
nidine
Allocated to group D-
Dexmedetomidine (n=30)
on (n=0)
Lost to follow-up (n=0)
Discontinued intervention (n=0)
•
Declined to participate 
(n=205)
•
nsolidated  Standards  of  Reporting  Trials).
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Table  1  Demographic  characteristics.
Patient  characteristics  Group  T  Group  C  Group  D  p-Value
Age  (years)  37.42  ±  6.27  36.84  ±  5.87  35.78  ±  6.76  0.596a
Body  weight  (kg)  66.65  ±  7.46  68.73  ±  8.34  67.34  ±  7.62  0.578a
Height  (cm) 166.34  ±  10.45 164.42  ±  11.23 162.72  ±  10.72 0.433a
ASA  physical  status  1/2 14/16  15/15  12/18  1.001a
Gender  (M/F)  12/18  13/17  12/18  0.667a
Mean  duration  of  anesthesia  (min)  62.43  ±  3.78  64.54  ±  4.42  63.32  ±  4.43  0.157a
Mean  axillary  temperature  (◦C)  36.88  ±  0.55  36.77  ±  0.14  36.83  ±  0.24  0.097a
All values are mean ± SD or numbers. Statistical analysis by One-way Analysis of Variance (ANOVA) with posttest.
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ANOVA)  test.  There  were  signiﬁcant  variations  in  the  heart
ate  after  the  administration  of  the  study  drug  between  the
hree  groups  and  is  depicted  in  Table  2.  There  was  reduction
n  heart  rate  in  dexmedetomidine  and  clonidine  group  with
o  signiﬁcant  changes  in  the  tramadol  group.  The  changes
n  systolic  and  diastolic  pressure  after  drug  administration
ere  given  in  Tables  3  and  4.  There  was  reduction  in  systolic
nd  diastolic  blood  pressure  more  so  in  the  dexmedetomi-
ine  group  than  clonidine  and  tramadol  groups.
The  sedation  score  was  signiﬁcantly  higher  in  thePlease  cite  this  article  in  press  as:  Venkatraman  R,  et  al.  A  p
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exmedetomidine  group  with  70%  of  patients  having  a  score
f  2%  and  23.3%  patients  developing  a  score  of  3  (Fig.  2).
owever,  no  patient  in  any  group  developed  a  score  of  4.
he  sedation  achieved  during  the  treatment  of  shivering  was
w
T
d
(
Table  2  Variations  in  heart  rate  after  study  drug  administration.
Time  (min)  Group  T  (beats/min)  Group  C  (beats/min)  
0  73.72  ±  4.68  74.9  ±  5.21  
10 76.83 ±  3.78 70.42  ±  3.17
20 74.41  ±  5.21 71.28  ±  5.39
30 70.5  ±  3.94  72.39  ±  4.27  
40 71.31  ±  3.19 71.43  ±  3.55
50  71.19  ±  4.82  72.37  ±  4.57  
60 72.1  ±  4.04  72.32  ±  4.44  
Statistical analysis by One-way ANOVA with posttest. All values are me
a Signiﬁcant.
b Highly signiﬁcant.
c Not signiﬁcant.
d Group T vs. Group C.
e Group T vs. Group D.
f Group C vs. Group D.eneﬁcial  for  these  patients  under  spinal  anesthesia.  The
ecurrence  rate  was  signiﬁcantly  less  in  the  dexmedetomi-
ine  group  (3.3%)  and  highest  in  the  tramadol  group  (23.3%).
he  clonidine  group  had  a  recurrence  rate  of  10%.  The  shive-
ing  was  not  controlled  in  two  patients  in  the  clonidine  group
nd  one  in  the  tramadol  group  and  rescue  drug  pethidine
as  used  for  them.  The  incidence  of  vomiting  was  higher
n  the  tramadol  group  (13.3%)  than  clonidine  (3.3%)  and
exmedetomidine  group  (0  patients).  However  two  patients
eveloped  bradycardia  each  in  the  dexmedetomidine  asrospective,  randomized,  double-blinded  control  study  on
ost  spinal  anesthesia  shivering.  Rev  Bras  Anestesiol.  2016.
ell  as  clonidine  group  which  responded  well  to  atropine.
he  incidence  of  hypotension  was  signiﬁcantly  higher  in  the
exmedetomidine  (20%)  than  clonidine  (13.3%)  and  tramadol
6.6%)  groups.
Group  D  (beats/min)  p-Value  Intergroup
comparison
when  p  <  0.05
74.41  ±  4.25  0.625c --
68.53  ±  2.49 <0.0001b <0.001d
<0.001e
0.013f
65.42  ±  4.95 <0.0001b 0.0259d
<0.001e
<0.001f
68.42  ±  4.83 0.002a 0.065d
0.060e
0.001f
69.39  ±  2.73 0.023a 0.890d
0.065e
0.023f
70.33  ±  5.03  0.258c --
71.49  ±  3.89  0.734c --
an ± SD.
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Table  3  Variations  in  systolic  blood  pressure  after  study  drug  administration.
Time  (min)  Group  T  (mm/Hg)  Group  C  (mm/Hg)  Group  D  (mm/Hg)  p-Value  Intergroup
comparison
when  (p  <  0.05)
0  108.32  ±  9.56 107.54  ±  8.72 108.47  ±  9.52 0.916c --
10 104.65 ±  7.41 102.53  ±  9.58 98.68  ±  10.72 0.047a 0.3417d
0.0149e
0.1478f
20  106.53  ±  8.63  98.8  ±  7.91  94.88  ±  8.48 <0.0001b 0.0006d
0.0001e
0.0692f
30  104.59  ±  8.29  103.5  ±  9.48  99.39  ±  9.48  0.069c --
40 104.89  ±  10.42  103.6  ±  6.92  103.77  ±  9.38  0.834c --
50 102.66  ±  6.83  104.7  ±  8.99  102.79  ±  10.29  0.582c --
60 103.58  ±  9.82  102.69  ±  10.69  102.29  ±  8.73  0.872c --
Statistical analysis by One-way ANOVA with posttest. All values are mean ± SD.
a Signiﬁcant.
b Highly signiﬁcant.
c Not signiﬁcant.
d Group T vs. Group C.
e Group T vs. Group D.
n
a
d
n
a
T
m
bf Group C vs. Group D.
Discussion
The  shivering  is  a  protective  response  occurring  as  part  of
a  centrally  mediated  thermoregulatory  defense  mechanism
to  hypothermia.11 The  shivering  is  a  frequent  complica-
tion  under  regional  anesthesia  occurring  either  as  a  result
of  a  decrease  in  core  body  temperature  or  misinformation
from  receptors.12 The  shivering  under  anesthesia  not  only
increases  the  oxygen  consumption  but  also  causes  tachycar-Please  cite  this  article  in  press  as:  Venkatraman  R,  et  al.  A  p
comparison  of  tramadol,  clonidine  and  dexmedetomidine  for  p
http://dx.doi.org/10.1016/j.bjane.2016.08.001
dia,  hypertension  and  interferes  with  the  monitoring  of  pulse
oximeter,  electrocardiogram  and  blood  pressure.  In  spite  of
the  availability  of  numerous  drugs  to  treat  shivering,  there  is
D
d
t
Table  4  Variations  in  diastolic  blood  pressure  after  study  drug  ad
Time  (min)  Group  T  (mm/Hg)  Group  C  (mm/Hg)  
0  75.63  ±  4.82  74.75  ±  5.86  
10 72.43  ±  6.18  70.83  ±  7.84  
20 71.88 ±  3.91 68.6  ±  5.28
30  70.96  ±  5.37  69.27  ±  6.39  
40 72.82  ±  6.49  71.15  ±  4.92  
50 74.7  ±  3.73  73.47  ±  6.20  
60 76.85  ±  4.72  77.28  ±  3.72  
Statistical analysis by One-way ANOVA with post-test. All values are me
a Not signiﬁcant.
b Highly signiﬁcant.
c Group T vs. Group C.
d Group T vs. Group D.
e Group C vs. Group D.o  consensus  drug  that  effectively  controls  shivering  without
ny  side  effects.
The  2 agonists  commonly  used  to  treat  shivering  acts  by
ecreasing  the  central  thermo  sensitivity  by  suppressing  the
euronal  conductance.13 They  decrease  the  release  of  nor-
drenaline  from  the  axonal  terminals  in  the  hypothalamus.14
here  is  high  density  of  2 receptors  in  the  hypothala-
us  and  these  receptors  activation  leads  to  hypothermia
y  reducing  the  generation  of  heat  by  metabolic  activity.15rospective,  randomized,  double-blinded  control  study  on
ost  spinal  anesthesia  shivering.  Rev  Bras  Anestesiol.  2016.
exmedetomidine  has  an  advantage  in  its  ability  to  produce
ose  dependent  sedation  and  can  be  used  as  an  anes-
hetic  adjuvant.16,17 Tramadol  acts  by  inhibiting  the  neuronal
ministration.
Group  D  (mm/Hg)  p-Value  Intergroup
comparison
when  (p  <  0.05)
76.33  ±  4.47  0.486a --
68.43  ±  6.38  0.081a --
66.18  ±  6.35 0.0003b 0.0083c
0.0001d
0.1139e
67.88  ±  4.72  0.103a --
70.19  ±  6.48  0.235a --
72.55  ±  5.62  0.292a --
75.66  ±  7.36  0.498a --
an ± SD.
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ptake  of  serotonin  and  noradrenaline  and  enhances  the
ydroxytryptamine  secretion.18
The  shivering  was  controlled  faster  in  the  dexmedeto-
idine  group  and  it  took  a  longer  time  in  the  clonidine
roup  than  tramadol  group.  Mittal  et  al.  performed  a
tudy  on  the  comparison  of  dexmedetomidine  and  tramadol
or  post  spinal  anesthesia  shivering.  They  concluded  that
exmedetomidine  in  a  dose  of  0.5  mcg/kg  had  a faster
nset  to  control  shivering  in  2.52  ±  0.44  min.19 Bansal  did
 comparative  study  on  control  of  shivering  with  cloni-
ine,  butorphanol  and  tramadol  under  spinal  anesthesia.
hey  reported  that  tramadol  was  more  effective  than
lonidine  in  suppressing  shivering.20 Usta  et  al.  conducted
 study  on  dexmedetomidine  infusion  for  the  prevention
f  shivering  during  spinal  anesthesia.  They  observed  that
exmedetomidine  infusion  of  0.4  mcg/kg/h  was  effective  in
reventing  shivering  and  providing  sedation  for  minor  surgi-
al  procedures.21
The  sedation  achieved  was  better  in  the  dexmedeto-
idine  group  than  clonidine  and  tramadol  group.  Since
he  surgery  was  done  under  spinal  anesthesia,  sedation
chieved  was  beneﬁcial  for  these  patients.  However,  none
f  the  patients  became  unarousable  in  all  the  three  groups.
ozgeyik  et  al.  performed  a  study  on  the  effects  of  pre-
mptive  tramadol  and  dexmedetomidine  on  shivering  during
rthroscopy.  They  observed  that  in  addition  to  its  effective-
ess  in  preventing  shivering,  dexmedetomidine  was  superior
n  increasing  the  level  of  sedation  to  prevent  anxiety  without
ide  effects.22
Only  one  patient  in  the  dexmedetomidine  group  devel-
ped  recurrence  of  shivering  whereas  seven  patients  in  the
ramadol  group  and  three  patients  in  the  clonidine  group
ncountered  recurrence  which  was  treated  with  pethidine.
ittal  et  al.  reported  the  shivering  recurrence  was  dou-
led  in  the  tramadol  group  than  dexmedetomidine  group.19
ansal  et  al.  reported  a  recurrence  of  26%  with  clonidine  and
0%  with  tramadol.20 These  studies  also  conﬁrm  that  recur-
ence  of  shivering  was  much  lower  in  the  dexmedetomidine
roup  than  tramadol  and  clonidine.Please  cite  this  article  in  press  as:  Venkatraman  R,  et  al.  A  p
comparison  of  tramadol,  clonidine  and  dexmedetomidine  for  p
http://dx.doi.org/10.1016/j.bjane.2016.08.001
The  vomiting  was  observed  more  frequently  in  the  tra-
adol  group  with  four  patients  and  one  patient  in  the
lonidine  group.  The  bradycardia  was  observed  in  two PRESS
R.  Venkatraman  et  al.
atients  each  in  clonidine  and  dexmedetomidine.  However,
he  incidence  of  hypotension  was  observed  more  frequently
n  the  dexmedetomidine  group.  But  hypotension  and  brady-
ardia  responded  well  to  treatment.  Kim  et  al.  reported
ypotension  in  6.6%  and  bradycardia  in  16.6%  of  patients
ith  dexmedetomidine  1  mcg/kg.23 Mittal  et  al.  did  not
ave  any  hypotension  with  dexmedetomidine  0.5  mcg/kg
nd  vomiting  in  20%  of  patients  with  tramadol.19
The  limitations  of  our  study  include  a  relatively  smaller
ize  sample.  Though  dexmedetomidine  was  effective  in  the
reatment  of  shivering,  side  effects  were  reported  with  it
hich  was  treatable.  A  larger  study  is  needed  to  report
n  ideal  drug  for  shivering.  Secondly,  we  did  not  measure
he  core  temperature  but  used  the  axillary  temperature  in
ll  patients.  Thirdly,  the  incidence  of  shivering  would  have
een  less  if  we  have  used  external  warming  devices  for  all
atients.
We  conclude  that  dexmedetomidine  is  more  effective
han  tramadol  and  clonidine  in  the  treatment  of  shive-
ing  because  of  its  faster  onset,  lesser  recurrence  rate,
nd  better  sedation.  The  complications  reported  with
exmedetomidine  were  easily  treatable  and  did  not  have
uch  clinical  impact.  Tramadol  is  better  than  clonidine  in
reating  shivering  but  has  more  incidence  of  unpleasant
omiting.
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